Resources
PM360 July 13, 2023 Read the full article>> Reasons for Discontinuation (RfD) Analytics Report An estimated 50% of patients with a prescription for a chronic condition stop taking it within the first year, leading to worse outcomes and nearly $250 billion lost revenue annually for the pharmaceutical industry. To combat this, OM1 launched its Reasons for Discontinuation[…]
Patti Peeples June 22, 2023 The Evidence Base Watch the full interview >>
PM360 MAY 25, 2023 Andrew Matthius Read the full article>> Mental health continues to be a national crisis that is only becoming more prevalent, especially since the pandemic. According to the National Alliance on Mental Illness (NAMI), 22.8% of U.S. adults experienced mental illness in 2021, which represents about 1 in 5 adults or 57.8 million[…]
Business Wire May 24, 2023 Read the full press release>> OM1 now offers a complementary suite of easy-to-digest analytics that give a real-world, 360° view of trends in treatment behaviors and patient outcomes May 24, 2023 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, outcomes, and technology company with a focus on chronic[…]
Taylor & Francis Online April 6, 2023 Read the full manuscript >> Objective: To investigate the impact of steroid-eluting implants after endoscopic sinus surgery (ESS) on health care resource use (HCRU) in chronic rhinosinusitis patients with (CRSwNP) and without (CRSsNP) nasal polyps. Methods: This retrospective, observational cohort study using real-world evidence data included adult patients[…]
